Exciting news! Pirouette has just received a Notice of Award from the National Institutes of Health (NIH) – they have awarded us an administrative supplement of $97K+ to expand the scope of our Phase I award. 💸🔬

For those who might not be familiar, our initial Phase I SBIR (Small Business Innovation Research) grant, valued at $327K, was awarded by the NIH and the National Institute on Drug Abuse (NIDA). This grant has been crucial in affirming the technical merit and commercial potential of our research, specifically targeting the development of our patented auto-injector technology. 

This supplement underscores the NIH's confidence in our work and its potential impact on healthcare. With this expanding scope, we can accelerate our progress toward FDA approval and commercialization, bringing us closer to revolutionizing the $600B market. 🙌

If you’re considering increasing your investment or know someone who might be interested in joining us, NOW is the time — our round is 95% subscribed and almost sold out!  ⏰

Invest or increase your investment today → wefunder.com/pirouette

To the future of injections!

Conor